Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/2010
06/16/2010CN101732241A Cream of butenafine hydrochloride and preparation method thereof
06/16/2010CN101732240A Externally used ointment for relieving pain and activating blood circulation
06/16/2010CN101732239A External ointment preparation for treating rabbit sarcoptidosis
06/16/2010CN101732238A Mitomycin c ophthalmic gel
06/16/2010CN101732237A Baicalin thermosensitive gelatin and preparation method and use thereof
06/16/2010CN101732236A Solid medicine preparation for preventing agglomeration and discoloration and preparation method thereof
06/16/2010CN101732235A Solid dispersion of tamoxifen citrate, method for preparing same and application thereof
06/16/2010CN101732234A Method for preparing block polymer micelle freeze-drying preparation carrying docetaxel
06/16/2010CN101732233A Method for preparing solid dispersion
06/16/2010CN101732232A Docetaxel nano-particle composition
06/16/2010CN101732231A Artemisine solid lipid nano-particles and preparing method thereof
06/16/2010CN101732230A Sustained-release preparation
06/16/2010CN101732229A Borneol inclusion compound and preparation method thereof
06/16/2010CN101731506A Health-care food of bee glue and wood frog lecithin capsule
06/16/2010CN101507772B Traditional Chinese medicine paste for treating mouth facial phlegmona and preparation method thereof
06/16/2010CN101491565B Use of Ixeris Sonchifolia Hance injection in preparing medicine for treating viral pneumonia
06/16/2010CN101390847B Ampicillin capsule and production method thereof
06/16/2010CN101390846B Amoxicillin capsule and production method thereof
06/16/2010CN101314046B Cyclodextrin inclusion method for hair orchid native
06/16/2010CN101306015B Composition for increasing embryo quality and preventing and curing defect baby from generating
06/16/2010CN101283965B Preparation containing bendopa methyl ester and preparation method thereof
06/16/2010CN101269051B Rumen bypass becholine microcapsule and preparation technique
06/16/2010CN101249184B Medicine for treating osteoproliferation as well as its preparation method
06/16/2010CN101249071B Preparation of 2-methoxyl group estradiol vena nano emulsions
06/16/2010CN101235155B Method for preparing polylactic acid, polyvinyl alcohol and brazilwood mixed nano or micron fibrous membrane
06/16/2010CN101224199B Anetholtnithoines and preparing method thereof
06/16/2010CN101219179B Chinese composition medicine for treating piles and method of preparing the same
06/16/2010CN101214353B Medicament for treating chicken myeloencephalitis
06/16/2010CN101214330B Rheumatism plaster and thread gluing type ventilating bagged rheumatism plaster and production method thereof
06/16/2010CN101214223B Closantel or its sodium salt long-acting sustained-release injection and preparation thereof
06/16/2010CN101204371B Vitamin C injection and preparation method thereof
06/16/2010CN101185637B Silybin dimer self-emulsifying microemulsion preparation and its manufacturing method
06/16/2010CN101181615B Plaster for curing neck shoulder waist leg pain affection as well as preparation method
06/16/2010CN101181610B External application medicament for curing dermatosis and preparation method thereof
06/16/2010CN101181502B Chinese medicine composition orally taken for curing chronic bronchitis
06/16/2010CN101171531B Ophthalmic devices for sustained delivery of active compounds
06/16/2010CN101167725B Nimodipine long circulating vesicle and its freezing-dried preparation
06/16/2010CN101152490B Traditional Chinese medicine antidiarrheal oral liquid, preparing method and application of the same
06/16/2010CN101147794B Traditional Chinese medicine for treating deficiency-cold type metrorrhagia and preparation method thereof
06/16/2010CN101143138B Paracetamol and pseudoephedrine hydrochloride tablets made by dry powder direct tabletting
06/16/2010CN101123947B Thickened spreadable warming lubricant
06/16/2010CN101120917B Compound amino acid injection composition suitable for kidney disease patient
06/16/2010CN101116684B Mongolian medicine for treating cerebrovascular disease
06/16/2010CN101100664B Method for preparing recombinant canine alpha-type interferon
06/16/2010CN101099850B Medicine composition for treating chronic active hepatitis and early-stage hepatocirrhosis and preparation method thereof
06/16/2010CN101095879B Chinese traditional medicine for treating tuberculosis disease and the preparation method thereof
06/16/2010CN101085302B Apply externally ointment for treating hyperplasia of mammary glands
06/16/2010CN101073656B Pear antitussive syrup with antasthmatic and lung-moistening functions
06/16/2010CN101062165B Citrus aurantium total flavone extract and the preparing method thereof
06/16/2010CN101053595B Medicinal preparation for treating constipation and its preparing method
06/16/2010CN101052373B Suction tablet containing octenidine for oral and pharyngeal cavity inflammation
06/16/2010CN101002912B Method for preparing Yueshu dripping pills to treat dysmenorrhea
06/15/2010US7737285 [3-(4-{2-butyl-1-[4-(4chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine, used as modulators of the interaction between the receptor for advanced glycated end products and its ligands; inflammation, nephropathy, atherosclerosis, retinopathy, Alzheimer's disease, erectile dysfunction
06/15/2010US7737240 for cells, proteins, DNA or other molecules encapsulation; carragenan, chitosan, hyaluronic acid, cellulose or alginate; with thiophene, aniline or pyrrole polymerizable moiety grafted on
06/15/2010US7737211 Adding nanofiller having polar end groups to a polymer melt in an extruder; adding an unsaturated shielding material such as maleic anhydride and causing it to react with the end groups to form a product that is then grafted to the polymer; nanofiller material is exfoliated; auto interiors and exteriors
06/15/2010US7737181 Topical adapalene for acne and other inflammatory or proliferative skin disorders
06/15/2010US7737133 Formulations and methods of treating inflammatory bowel disease
06/15/2010US7737130 Pharmaceutical compositions for topical use in treatment of skin or mucous injuries
06/15/2010US7737108 Enhanced transport using membrane disruptive agents
06/15/2010US7736885 Method for production of arachidonic acid
06/15/2010US7736679 comprises curcumin and an essential oil of turmeric
06/15/2010US7736674 Controlled release compositions for interferon based on PEGT/PBT block copolymers
06/15/2010US7736673 Stabilized pharmaceutical product
06/15/2010US7736672 Forming multiparticulates comprising drug, carrier, and an optional dissolution enhancer, treating said multiparticulates by heating, exposing to a mobility-enhancing agent; increase in drug crystallinity, and in some embodiments improved chemical, physical, dissolution stability
06/15/2010US7736671 Embolization
06/15/2010US7736670 The invention relates to a method for making composite active particles for use in a pharmaceutical composition for pulmonary administration, the method comprising a milling step in which particles of active material are milled in the
06/15/2010US7736669 Porous structures, and methods of use
06/15/2010US7736668 A delayed delivery drug dose to a fluid environment consists of a dose of drug, a second formulation with imbibes fluid and expands, a wall that confines both and permeable to the passage of fluid, a subcoat of hydroxyalkyl cellulose
06/15/2010US7736667 Release rate constant over time for several hours within the early part of the release profile, confining the release to the upper GI tract; shell remains intact during entire period of drug release
06/15/2010US7736666 Consists of naproxen, a butyl spacer and a nitrogen oxide (NO)-releasing nitrate group, linked together into a single molecule; useful as antiinflammatory agent and an analgesic
06/15/2010US7736665 Implantable polymeric device for sustained release of buprenorphine
06/15/2010US7736647 an antigen binding fragment comprising a heavy chain and a light chain variable region amino acid sequences, associated to effector cells for triggering antibody-dependent cell-mediated cytotoxicity (ADCC) mechanisms; useful for inhibiting proliferation and/or killing melanoma cells
06/15/2010US7736628 Mixing a lactose fraction with small particle size with a carrier lactose contains amorphous lactose, exposing lactose mixture to a relative humidity of 85 % at a temp. from 20-40 degree C., then relative humidity of less than 20% at a temp.70 degree C. so that a modified lactose mixture is produced
06/15/2010US7736627 The invention relates to propellant gas formulations containing suspensions of the crystalline monohydrate of (1 7-((hydroxydi-2-thienylacetyl)oxy)-9, 9-dimethyl-3-oxa-9-azoniatricyclo(3.3.1.02,4)nonane-bromide, with a simple monoclinic cell, and one or more adjuvants
06/15/2010US7736626 HFA supension formulations containing an anticholinergic
06/15/2010US7736622 Methods of diagnosing small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
06/15/2010US7736309 Implantable sensor method and system
06/15/2010US7735485 Dry powder inhalation system for transpulmonary administration
06/15/2010CA2687017A1 Method for manufacturing edible film
06/15/2010CA2578709C Compositions comprising a mucoadhesive protein and an active principle for mucosal delivery of said agents
06/15/2010CA2481868C Preparation of powder agglomerates
06/15/2010CA2466103C Micelle compositions containing pegylated phospholipids and a photosensitizer
06/15/2010CA2442104C Prosthetic foot with tunable performance
06/15/2010CA2422975C Infusion pump with access regulator
06/15/2010CA2407072C Taste masking coating composition
06/15/2010CA2404696C Medicament containing tissue inhibitor of metalloproteinases-2 (timp-2) as an osteoanabolically active substance
06/15/2010CA2398668C Delivery systems using preformed biodegradable polymer compositions and methods
06/15/2010CA2335505C Novel triterpenoids and their use for the treatment and prevention of cancer, inflammatory disorders, and neurodegenerative disease
06/10/2010WO2010065843A2 Biologic scaffold for prevention of pulmonary fibrosis
06/10/2010WO2010065784A2 Methods, devices, and compositions for dermal filling
06/10/2010WO2010065751A2 Formulations of guanylate cyclase c agonists and methods of use
06/10/2010WO2010065730A2 Pharmaceutical suspension
06/10/2010WO2010065686A1 Ophthalmic devices for delivery of hydrophobic comfort agents
06/10/2010WO2010065660A2 Biodegradable polydisulfide amines for gene delivery
06/10/2010WO2010065563A2 Apratoxin therapeutic agents: mechanism and methods of treatment
06/10/2010WO2010065513A1 Method of making sustained release microparticles
06/10/2010WO2010065492A1 Alpha2-adrenergic agonist a calcium channel blocker composition
06/10/2010WO2010065489A1 Alpha2-adrenergic agonist and angiotensin ii receptor antagonist composition
06/10/2010WO2010065456A2 Flowable pharmaceutical depot
06/10/2010WO2010065329A2 Nanoparticles for cancer treatment
1 ... 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 ... 2991